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NIFEDIPINE GITS REDUCES ANGINA AND AMBULATORY ISCHEZIA 
OVER 24 HOURS: RESULTS OF THE NIFEDIPINE CIRCADIAN 
ANTI-ISCHEHIC PROGRAM (N-CAP) MULTICENTER TRIAL. 
William Parmley, UC San Francisco, For the N-CAP Study 
Group 
We studied the effects of once daily nifedipine 
(N-GITS) in 207 stable angina pts (92 on monotherapy 
and 115 on B-blocker) with 22 angina attacks/wk and 22 
ischemic episodes (IE), on ambulatory ECG monitoring 
(AECG) and angina in a single-blind trial. 48 hr 
digital AECG was performed after 1 week placebo run-in 
(P), 9 wks N-GITS (30-18Omg). and 2 wks placebo washout 
(PW). IE on AECG were significantly reduced (P 7.3/48 
hr, N-GITS 4.0, p-0.0001; mean reduction 45%) and 
significantly increased during PW (5.2. p-O.011 vs 
N-GITS). This was paralleled by significant reductions 
in weekly angina (P 5.7, N-GITS 1.8, PW 3.9, p-00001 
for both comparisons) and NTG use (P 4.1. N-GITS 1.6, 
PW 3.3; p-.0001 for both comparisons). Reductions in IE 
on AECG, angina, and NTG - 
use were found with 15 
BER OF EVENTS 
N-GITS when used alone or 1.2 
when added to B-blockers. . 
A circadian variation of Go8 
AECG events was present h 
at baseline and N-GITS Ioe 
significantly reduced the 2 
number of events at each 01) 
time interval over 24 
hours (Figure). 
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Thans,once daily N-GITS markedly reduced subjective and 
objective evidence ofischemia over the whole day, both 
as monotherapy and in combination with B-blockers. 
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In order to investigate if 
in the h an heart of end 
short-ter effects of ESES na pectoris, 
severe CAD underweat a P 
patients with 
sided catheterization with 
acing via a catheter in the coronary sinus. Blood samples 
multaneously drawn from a peripheral artery and the 
coronary sinus in the heart for later assay of lactate and endoge- 
nous opioid concentration. The heart was paced to anginal 
symptoms during a control session and during treatment with 
ESES. An epidural stimdator had previously been implanted 
for antianginal treatment. 
Results: There was a net release from the myocardium in al! 
ws of beta-endorphins (BE), leu-enkephahn (L-enk), 
met-enkephalin (M-enk) and dynorphin (Dyn). Treatment with 
ESES increased tolerance to pacing (12938 compared to 15Ir17 
beats/minute; ~(0.05) and improved lactate metabolism (lactate 
during control, -7%%3%, turned to extraction, 
0.05). At maximal pacing rate where all patients 
nal pain, myocardial lactate extraction turned 
to production (9+16% compared to -223%: ec0.05). 
Conclusions: 
. _ 
n heart is capable of releasing the ooioid oestide 
-enk and Dti. Enkeph 
delta-receptors on 
cardium, which inhibit 
sponse following sympathetic stimulation. 
have an antiangkd effect 
There was also a tendency 
of BE and L-enk during 
5 patients studied. 
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The prognositc significance of silent ischemia (SI) was 
studied in 50 patients with stable angina pgctoris (Ap) 
who had been medically treated to ce 
Bach patient had e 
angiography, exerci 
arction, or classic Ap. All patients had 
BP that was controlled with medical therapy; nitrates 
64%, calciun blockers 64%, beta-blockers 28%, aspirin 78%. 
I4lTbulatory Halter m?Xlitor was performed for 36+12 
hours. Ischemia was defi as ST segment depression of 
>lnm for>60 sea&s. Seventeen patients (34%) had is- 
ckinia; 16 (32%) kd SI, 1 (2%) had AP, and 1 (2%) had 
tied angina. Ischeznic episodes ranged from 1-14 per 
patient hedian 5) with a mean total ischemic time of 143 
tin/patient. Sixteen cardiac events (unstable angina 10, 
need for revascularization 4, sudden death 2) occurred 
during a m follow-up of 10 nrMhs (range 1-31 months) . 
The event free survival at 10 n0nths was 79% in the non- 
SI group and 39% in the S1 group; the &if ference was sig- 
nificant at KO.02. The persistence of SI after the 
control of Ap identifies a high risk subset. 
